The following is a searchable and filterable list of our news posts, press releases, white papers, articles, scientific posters, and much more.
If you can’t find something, please let us know and we’ll reach out to you as soon as we can.
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
Schell, MJ. Nat Commun. 2016;7:11743Open resourceBioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer
Malgerud, L. et al. Mol Oncol. 2017;11(10):1413-1429Open resourceConsolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide
Hirotsu, Y. et al. Int J Mol Sci. 2020;21(11):3895Open resourceMH Guide as IVDR-certified product and part of your complete solution for NGS-based molecular tumor profiling
MH Guide as IVDR-certified product and part of your complete solution for NGS-based molecular tumor profiling.Read moreCatalogue of peer-reviewed studies 2009 – 2023
Read moreSt. Marianna University School of Medicine in Japan relies on MH Guide for personalized cancer medicine
Press release, October 27, 2023Read moreMolecular Health and Takara Bio collaborate to support Genome Medicine in Japan
Press release, October 13, 2023Read moreWhole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer – A Feasibility Study
Jaeger, BAS. Geburtshilfe Frauenheilkd. 2023;83(9):1138-1147Open resourceAnalysis and Clinical Relevance of Tumor Mutational Burden
A description of TMB as potential biomarker.Read moreRewiring Drug Research and Development through Human Data-Driven Discovery (HD3)
Jackson, D.B. et al. Pharmaceutics 2023, 15(6), 1673Open resourceDetermination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
Mustea, A. et al. Cancers 2023, 15(7), 2023Open resourceCurrently no job listings
Read moreMH Guide 6.0: Next-level automation and precision in the clinical interpretation of cancer genomic profiling
Press release, 15 February 2023Read moreWhole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms
Brock, S. et al. Front. Mol. Med. 2023, 2:1035290. https://doi.org/10.3389/fmmed.2022.1035290Open resourceDaten töten. Den Krebs.
An article by Friedrich von Bohlen in FOCUS Die Welt in 2023 (in German)Download articleMolecular Health receives IVDR certification for MH Guide
Press release, 13 July 2022Read moreMolecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
Press release, 10 March 2022Read moreAdvancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports
Soldatos, T. G. et al. CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):540-555. doi: 10.1002/psp4.12765Open resourceEvaluation of the TruSight Tumor 170 Assay and Its Value in Clinical Diagnostics
Heydt, C. et al. J. Mol. Pathol. 2022, 3(1), 53-67; https://doi.org/10.3390/jmp3010006Open resourceDiscover the benefits of automated variant annotation for your clinical routine
MH Guide interprets complex genetic data quickly and accurately – for the growing challenges of today and tomorrowRead moreApplication of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors
Kim, S. et al. Clin Transl Sci. 2022 Jun;15(6):1430-1438. doi: 10.1111/cts.13254Open resourceThe COVID-19 explorer – An integrated, whole patient knowledge model of COVID-19 disease
Brock, S. et al. Front. Mol. Med. 2022, 2:1035215. https://doi.org/10.3389/fmmed.2022.1035215Open resourceThe earlier, the better – turning data into knowledge
Predisposition analyses of hereditary cancersRead moreMolecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey
Press release, 19. October 2021Read moreMolecular Health and Essen University Hospital launch collaborative project to improve care for COVID-19 patients
Press release, 9 August 2021Read moreKonyang University Hospital in South Korea relies on MH Guide for personalized cancer medicine
Press release, 16 July 2021Read moreWir bringen die biologische Grammatik in die Medizin
Plattform Life Sciences “Smarte Medizin” – Interview with Friedrich von Bohlen (in German)Open resourceTarget adverse event profiles for predictive safety in the postmarket setting
Peter Schotland, Rebecca Racz, David B. Jackson, Theodoros G. Soldatos, Robert Levin, David G. Strauss and Keith Burkhart. Clinical Pharmacology & Therapeutics Volume 109, Issue 5, Pages: 1159-1362 (May 2021)Open resourceMH Guide: Molecular tumor diagnostics in 7 steps
An overview of the MH Guide workflow from hotspot to gene profileRead morePanel diagnostics instead of hotspot? Here are the differences
An overview of the pros and cons of using NGS-based panels for molecular tumor profilingRead moreMolecular Health – intelligent solutions for smarter healthcare
NATURE BiopharmaDealmakersOpen resource70-year-old with recurrent ovarian cancer
The story of new hope for an ovarian cancer patient thanks to MH Guide.Read moreMH Guide: six questions and answers
A list of answers to commonly asked questions about tertiary analysis solutions like MH Guide.Read moreMolecular Health and FALCO biosystems team up to provide genetic analysis services using MH Guide/BRCA and MH Guide/Mendel
Press release, 2 March 2021Read moreMolekulare Diagnostik beim Mammakarzinom – Wo stehen wir auf dem Weg zur molekular stratifizierten Therapie?
ÄrzteZeitung – SpringerMedizin (in German)Open resourceDatenprojekt zu Covid-Langzeitfolgen startet
Handelsblatt (in German)Open resourceWie der MH Corona Explorer die Versorgung COVID-19-Kranker verbessern soll
ÄrzteZeitung (in German)Open resourceA case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development
Kim, S. et al. Clin Transl Sci . 2022 Apr;15(4):1003-1013. doi: 10.1111/cts.13219Open resource